Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation
NCT ID: NCT00801567
Last Updated: 2012-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2010-06-30
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PET and MRI Brain Imaging of Bipolar Disorder
NCT01880957
Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
NCT00457054
Bipolar Depression Before and After Lamotrigine Treatment
NCT01042496
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
NCT00596622
Bipolar Research Study Using MR Imaging
NCT02083978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
All subjects will receive the intervention (MRS scan).
Magnetic resonance spectroscopy (MRS)
90-minute magnetic resonance scan.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnetic resonance spectroscopy (MRS)
90-minute magnetic resonance scan.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-55 years
* Bipolar, currently euthymic OR schizophrenia, stable, OR healthy control with no history of psychiatric illness
* On stable medication with no changes in the two weeks prior to enrollment
Exclusion Criteria
* Positive urine drug screen
* Significant medical or neurological illness
* Pregnancy
* Any contraindication to magnetic resonance scanning, including claustrophobia
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mclean Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brian P. Brennan, MD
Associate Director of Translational Neuroscience Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian P Brennan, MD
Role: PRINCIPAL_INVESTIGATOR
Mclean Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
McLean Hospital
Belmont, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-P-001958
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.